"Cobicistat" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carbamate and thiazole derivative that functions as a CYTOCHROME P450 CYP3A INHIBITOR to enhance the concentration of ANTI-HIV AGENTS, with which it is used in combination, for the treatment of HIV INFECTIONS.
| Descriptor ID |
D000069547
|
| MeSH Number(s) |
D02.241.081.251.203 D02.886.675.182 D03.383.129.708.189
|
| Concept/Terms |
GS 9350- GS 9350
- 9350, GS
- GS9350
- GS-9350
|
Below are MeSH descriptors whose meaning is more general than "Cobicistat".
Below are MeSH descriptors whose meaning is more specific than "Cobicistat".
This graph shows the total number of publications written about "Cobicistat" by people in this website by year, and whether "Cobicistat" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cobicistat" by people in Profiles.
-
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg. J Int AIDS Soc. 2025 Feb; 28(2):e26414.
-
Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. Lancet HIV. 2016 12; 3(12):e561-e568.